AMS (American Shared Hospital Services) 5-Year EBITDA Growth Rate: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMS American Shared Hospital Services AMS
51 GF Score
Price $1.48
GF Value $3.42
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is American Shared Hospital Services 5-Year EBITDA Growth Rate?

American Shared Hospital Services AMS -0.34% 51 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates AMS with a GF Score™ of 51/100 and a GF Value™ of $3.42 (Possible Value Trap). The stock has 7 warning signs investors should review.

American Shared Hospital Services's EBITDA per Share for the three months ended in Mar. 2026 was $0.11.

During the past 12 months, American Shared Hospital Services's average EBITDA Per Share Growth Rate was -47.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -21.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of American Shared Hospital Services was 72.10% per year. The lowest was -45.20% per year. And the median was -1.40% per year.


American Shared Hospital Services  (AMEX:AMS) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


American Shared Hospital Services 5-Year EBITDA Growth Rate Related Terms


AMS vs SYRA, BMGL, BICX: 5-Year EBITDA Growth Rate Comparison

For the Medical Care Facilities subindustry, American Shared Hospital Services's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Shared Hospital Services 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, American Shared Hospital Services's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where American Shared Hospital Services's 5-Year EBITDA Growth Rate falls into.


AMS
51GF Score
American Shared Hospital Services AMS
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

American Shared Hospital Services 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
American Shared Hospital Services (AMS) has a 5-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for American Shared Hospital Services and its competitors.
Is American Shared Hospital Services' 5-Year EBITDA Growth Rate too high?
American Shared Hospital Services' current 5-Year EBITDA Growth Rate is 0.00%. Overall, American Shared Hospital Services has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does American Shared Hospital Services' 5-Year EBITDA Growth Rate compare to SYRA and BMGL?
American Shared Hospital Services' 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for American Shared Hospital Services and its competitors. American Shared Hospital Services's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Shared Hospital Services stock overvalued right now?
Based on GuruFocus' analysis, American Shared Hospital Services (AMS) is currently considered Possible Value Trap. The stock's GF Value™ is $3.42, compared to a current price of $1.48 — trading 56.7% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. American Shared Hospital Services' overall GF Score™ is 51/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For American Shared Hospital Services (AMS), the current 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is American Shared Hospital Services (AMS) Overvalued in 2026?

Based on GuruFocus' analysis, American Shared Hospital Services stock appears to be undervalued. The current stock price of $1.48 is trading 56.7% below its estimated GF Value™ of $3.42. GuruFocus considers American Shared Hospital Services to be Possible Value Trap.

Key valuation signals for AMS:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: $3.42 vs. price of $1.48 (56.7% below fair value)
  • GF Score™: 51/100 with 7 warning signs

No single metric tells the full story. See the AMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


American Shared Hospital Services Business Description

Address 601 Montgomery Street, Suite 850, San Francisco, CA, USA, 94111-2619
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. Company operates in two segments, the medical equipment leasing segment where a contract exists between the hospital and the Company and the direct patient services segment, where a contract exists between the Company facilities and the individual treated at the facility. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates it's key revenue from the domestic market.
51GF Score

Get the complete analysis for AMS

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.48
Price
$3.42
GF Value